EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND

BOSTON, Sept. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary transcatheter... | September 17, 2022

Related Keywords

Boston , Massachusetts , United States , Canada , Philippe Genereux , Firas Zahr , Konstantinosp Koulogiannis , Megan Coylewright , Paula Grayburn , Jacobm Mishell , Bernardj Zovighian , Raj Makkar , Edwards Lifesciences , Lindad Gillam , Instagram , Linkedin , Twitter , Exchange Commission , Prnewswire Edwards Lifesciences Corporation , Youtube , Securities Exchange , Edwards Lifesciences Corporation , Facebook , Cardiovascular Research Foundation , Lifesciences Corporation , Transcatheter Cardiovascular Therapeutics , Scott Lim , Advanced Heart Valve Center , Virginia Health System , Prospective Registry , Transcatheter Edge To Repair , Complex Mitral Valve Anatomy , Late Breaking Presenter , Dive Session , Ralph Stephan , Bioprosthetic Valve Fracture , Patients Undergoing Valve , Failed Surgical Valves Using , Ultra Valves , Insights From Real World Data , Life After Aortic Valve Replacement , Edge To Repair , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Edwards Lifesciences Corporation Stock Exchange , News , Information , Press Release , 022 , Edwards , Lifesciences , Corporation , Nnounced , Results , Rom , Clasp , The , First , Randomized , Ontrolled , Trial , Hat , Irectly , Compares , Two , Ontemporary Ew Us28176e1082 ,